Pacific Biosciences of California (PACB) — Financial Flexibility Index
Pacific Biosciences of California (PACB) has a Financial Flexibility Index of -0.05x as of March 2026. Free cash flow of $-41.65 Million (operating CF $-44.69 Million minus capex $3.04 Million) represents 0% of total liabilities ($780.00 Million). Check strategic asset allocation of Pacific Biosciences of California to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Biosciences of California Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Pacific Biosciences of California across 18 annual periods. See PACB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Pacific Biosciences of California (2008–2025)
Year-by-year free cash flow to debt coverage for Pacific Biosciences of California. For the full company profile including market capitalisation, see how much is Pacific Biosciences of California worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.14x | $-108.50 Million | $-111.21 Million | $778.73 Million | ▲ +47.5% |
| 2024 | -0.27x | $-199.87 Million | $-206.06 Million | $753.85 Million | ▼ -7.5% |
| 2023 | -0.25x | $-257.70 Million | $-266.55 Million | $1.04 Billion | ▼ -20.6% |
| 2022 | -0.20x | $-246.28 Million | $-263.21 Million | $1.20 Billion | ▼ -136.3% |
| 2021 | -0.09x | $-105.25 Million | $-111.18 Million | $1.22 Billion | ▼ -133.1% |
| 2020 | 0.26x | $20.54 Million | $19.50 Million | $78.49 Million | ▲ +132.3% |
| 2019 | -0.81x | $-75.48 Million | $-78.31 Million | $93.07 Million | ▲ +29.4% |
| 2018 | -1.15x | $-64.58 Million | $-66.43 Million | $56.21 Million | ▼ -16.7% |
| 2017 | -0.98x | $-57.09 Million | $-67.52 Million | $57.98 Million | ▲ +12.3% |
| 2016 | -1.12x | $-59.72 Million | $-67.93 Million | $53.22 Million | ▼ -44.0% |
| 2015 | -0.78x | $-44.88 Million | $-47.89 Million | $57.57 Million | ▼ -8.8% |
| 2014 | -0.72x | $-49.86 Million | $-51.47 Million | $69.57 Million | ▼ -66.0% |
| 2013 | -0.43x | $-28.92 Million | $-29.83 Million | $67.00 Million | ▲ +88.3% |
| 2012 | -3.70x | $-75.12 Million | $-76.82 Million | $20.30 Million | ▼ -6.1% |
| 2011 | -3.49x | $-93.69 Million | $-102.97 Million | $26.85 Million | ▲ +22.6% |
| 2010 | -4.51x | $-116.74 Million | $-122.00 Million | $25.88 Million | ▼ -1701.5% |
| 2009 | -0.25x | $-69.66 Million | $-74.84 Million | $278.22 Million | ▼ -58.6% |
| 2008 | -0.16x | $-32.60 Million | $-38.30 Million | $206.50 Million | — |